These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 31147126)
21. Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses. Dorigo W; Pulli R; Piffaretti G; Castelli P; Griselli F; Dorrucci V; Ferilli F; Ottavi P; De Blasis G; Scalisi L; Monaca V; Battaglia G; Vecchiati E; Casali G; Pratesi C J Cardiovasc Surg (Torino); 2012 Apr; 53(2):187-94. PubMed ID: 22456641 [TBL] [Abstract][Full Text] [Related]
22. Factors Affecting Long-Term Results of Above-Knee Femoropopliteal Bypass: A Single-Center Contemporary Study. De Santis F; Pattaro C; Mani G; Pramstaller PP; Loreni G; Martini G Vasc Endovascular Surg; 2016 Feb; 50(2):72-9. PubMed ID: 26983664 [TBL] [Abstract][Full Text] [Related]
23. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. Brumberg RS; Back MR; Armstrong PA; Cuthbertson D; Shames ML; Johnson BL; Bandyk DF J Vasc Surg; 2007 Dec; 46(6):1160-6. PubMed ID: 17920227 [TBL] [Abstract][Full Text] [Related]
24. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass. Assadian A; Eckstein HH; J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193 [TBL] [Abstract][Full Text] [Related]
25. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass. Rychlik IJ; Davey P; Murphy J; O'Donnell ME J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288 [TBL] [Abstract][Full Text] [Related]
26. Long-term results of PTFE trilaminate graft versus venous graft and composite graft for below-the-knee revascularization. Mazzaccaro D; De Febis E; Settembrini AM; Tassinari L; Carmo M; Settembrini PG J Cardiovasc Surg (Torino); 2014 Oct; 55(5):685-91. PubMed ID: 25008059 [TBL] [Abstract][Full Text] [Related]
27. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study. Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of Long-Term Outcomes of Femoropopliteal Bypass Surgery in Patients With Chronic Limb-Threatening Ischemia in an Endovascular Era. Betz T; Ingolf T; Markus S; Florian Z; Christian U Ann Vasc Surg; 2022 Feb; 79():191-200. PubMed ID: 34644653 [TBL] [Abstract][Full Text] [Related]
29. A Randomized Controlled Trial Comparing Crude Versus Heparin-Bonded PTFE Graft in Below the Knee Bypass Surgery for Critical Limb Ischemia (REPLACE Trial): Design and Protocol. Gouëffic Y; Favre JP; Steinmetz E; Ordureau A; Riche VP; Guyomarch B; Rosset E Ann Vasc Surg; 2019 Jul; 58():115-121. PubMed ID: 30769063 [TBL] [Abstract][Full Text] [Related]
30. Autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene as graft materials for below-the-knee femoro-popliteal bypass in patients with critical limb ischemia: A propensity score-matched analysis. Dorigo W; Fargion A; Bassoli G; Di Domenico R; Giacomelli E; Piffaretti G; Alessi Innocenti A; Pratesi C Surgeon; 2022 Apr; 20(2):85-93. PubMed ID: 33685832 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Cryopreserved Arterial Allografts Versus Heparin-bonded Vascular Grafts in Infragenicular Bypass for Chronic Limb Threatening Ischemia. Hirth-Voury A; Massiot N; Giauffret E; Behets C; Duprey A; Hassen-Khodja R; Jean-Baptiste E; Sadaghianloo N Ann Vasc Surg; 2020 Apr; 64():33-42. PubMed ID: 31629123 [TBL] [Abstract][Full Text] [Related]
33. Budget impact analysis of heparin-bonded polytetrafluoroethylene grafts (Propaten) against standard polytetrafluoroethylene grafts for below-the-knee bypass in patients with critical limb ischaemia in France. Vergnaud S; Riche VP; Tessier P; Mauduit N; Kaladji A; Gouëffic Y BMJ Open; 2018 Feb; 8(2):e017320. PubMed ID: 29490953 [TBL] [Abstract][Full Text] [Related]
34. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial. Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876 [TBL] [Abstract][Full Text] [Related]
35. Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia. Suckow BD; Kraiss LW; Stone DH; Schanzer A; Bertges DJ; Baril DT; Cronenwett JL; Goodney PP; Ann Vasc Surg; 2013 Nov; 27(8):1134-45. PubMed ID: 24011814 [TBL] [Abstract][Full Text] [Related]
37. Long-term results of the heparin-bonded Viabahn stent graft in femoropopliteal TASC C and D lesions with a covered stent length of minimum 25 cm. Uhl C; Dadras A; Reichmann F; Betz T; Zorger N; Toepel I; Steinbauer M Vascular; 2019 Oct; 27(5):553-559. PubMed ID: 30917750 [No Abstract] [Full Text] [Related]